Anti-TNF therapy has been studied in patients with cancer [33], cardiovascular disease [45], as well as kidney disease [46, 47], whether also anti-TNF therapy can be beneficial in Type 2 diabetes remains, as far as we know, to be studied. The gene discussed is TNF; the disease is type 2 diabetes mellitus.